al response to drugs, we recognized a need for better and personalized predictive patient care and an opportunity to leverage the microbiome to deliver safer and more efficacious drug therapies. We started AlphaBiomics with the mission to develop microbiome-based precision medicine solutions that will predict drug response and improve drug therapy.